Previous Article | Next Article ![]()
Clinical and Vaccine Immunology, January 2007, p. 106-109, Vol. 14, No. 1
1071-412X/07/$08.00+0 doi:10.1128/CVI.00216-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

BioVeris Corporation, Gaithersburg, Maryland 20877
Received 8 June 2006/ Returned for modification 7 July 2006/ Accepted 22 October 2006
Antibodies to a modified group B meningococcal polysaccharide vaccine were examined for antigenic and functional specificities. Bactericidal determinants were investigated by using immunoaffinity columns and competitive inhibition of bactericidal activity in an in vitro killing assay. We conclude that nearly all of the vaccine-induced bactericidal activity is specific for the native polysaccharide.
Published ahead of print on 1 November 2006.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»